Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Compass Therapeutics ( (CMPX) ) just unveiled an update.
Compass Therapeutics has appointed Barry Shin as Chief Financial Officer, bringing over two decades of experience in finance and the biopharmaceutical industry. With past roles at Trevena, Inc. and investment banking firms, Shin’s expertise is expected to advance Compass’s clinical and pre-clinical assets, including the promising CTX-009. His appointment comes as the company anticipates key catalysts in 2025, aiming to deliver value to shareholders.
Learn more about CMPX stock on TipRanks’ Stock Analysis page.
